Form 4: ICAD Director's Options Converted Following RadNet Merger Completion

ICAD, Inc. Director Hedvig Hricak's stock options were converted or terminated as a result of the company's merger with RadNet, Inc., which became effective on July 17, 2025.

Summary

• ICAD, Inc. completed its merger with RadNet, Inc. on July 17, 2025, with Trio Merger Sub, Inc. merging with and into ICAD.
• Each outstanding share of ICAD common stock was automatically canceled and converted into the right to receive 0.0677 shares of RadNet common stock.
• Eligible ICAD stock options, defined as those with an exercise price less than $7.20, were assumed by RadNet and converted into options to purchase RadNet stock based on the 0.0677 exchange ratio.
• Any outstanding and unexercised ICAD options that were not eligible (i.e., exercise price of $7.20 or greater) terminated and ceased to be outstanding as of the Effective Time without any consideration.
• Director Hedvig Hricak's 40,000 stock options at an exercise price of $1.36, 5,415 options at $1.52, 30,000 options at $2.06, and 6,641 options at $3.69 were disposed of as part of this merger, resulting in zero ICAD derivative securities beneficially owned following the transaction.

Sentiment

Score: 7

Explanation: The sentiment is generally positive as a strategic merger was completed, and eligible option holders had their interests converted rather than simply terminated. However, the termination of out-of-the-money options and the cessation of ICAD as an independent entity introduce some negative aspects.

Positives

• The merger provides former ICAD shareholders with shares in a larger, publicly traded entity, RadNet, potentially offering greater liquidity and diversification.
• Eligible option holders, including Director Hedvig Hricak, had their options converted into RadNet options, preserving their equity interest in the combined entity.

Negatives

• ICAD, Inc. ceased to exist as a standalone public company, meaning its stock is no longer traded independently.
• ICAD options with an exercise price of $7.20 or greater terminated without any consideration, resulting in a loss for those specific option holders.

Risks

• Integration risks are present in combining ICAD's operations and technologies with RadNet's existing business.
• Potential for dilution for existing RadNet shareholders due to the issuance of new shares for the acquisition.
• Market value fluctuations of RadNet stock post-merger could impact the ultimate value received by former ICAD shareholders and option holders.

Future Outlook

The merger's completion signifies the integration of ICAD's operations and technologies into RadNet, aiming to enhance RadNet's offerings in diagnostic imaging. The future outlook for former ICAD shareholders and eligible option holders is now tied to RadNet's performance and strategic direction.

Industry Context

This merger represents a consolidation within the healthcare diagnostic imaging and AI sector. RadNet, a leading provider of outpatient diagnostic imaging services, is acquiring ICAD, a company specializing in AI-powered cancer detection solutions. This move aligns with a broader industry trend towards integrating advanced technology, particularly AI, into healthcare services to improve diagnostic accuracy and efficiency.

Management Changes

Stakeholder Impact

• Shareholders of ICAD, Inc. received RadNet, Inc. common stock, converting their investment into shares of the acquiring company.
• Eligible ICAD option holders had their options converted into RadNet options, maintaining their equity incentive in the combined entity.
• ICAD employees, particularly those with options, are impacted by the change in company ownership and the integration into RadNet.

Next Steps

• Integration of ICAD's operations and technologies into RadNet.
• Former ICAD shareholders will now hold RadNet stock and be subject to RadNet's future performance.

Key Dates

Keywords

ICAD, RadNet, Merger, Acquisition, Stock Options, SEC Form 4, Beneficial Ownership, Healthcare Technology, Medical Imaging, Corporate Action